Kim S Sugamori Selected Research

4-biphenylamine

1/2020	The impact of sex on hepatotoxic, inflammatory and proliferative responses in mouse models of liver carcinogenesis.
1/2019	Primary aromatic amines and cancer: Novel mechanistic insights using 4-aminobiphenyl as a model carcinogen.
12/2016	Influence of sex and developmental stage on acute hepatotoxic and inflammatory responses to liver procarcinogens in the mouse.
4/2015	N-hydroxylation of 4-aminobiphenyl by CYP2E1 produces oxidative stress in a mouse model of chemically induced liver cancer.
6/2012	Influence of arylamine N-acetyltransferase, sex, and age on 4-aminobiphenyl-induced in vivo mutant frequencies and spectra in mouse liver.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kim S Sugamori Research Topics

Disease

6	Neoplasms (Cancer) 01/2019 - 05/2012
3	Carcinogenesis 01/2019 - 07/2003
2	Liver Neoplasms (Liver Cancer) 01/2020 - 04/2015
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2018 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 07/2015 - 04/2015
1	Fibrosis (Cirrhosis) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Insulin Resistance 12/2020
1	Glucose Intolerance 12/2020
1	Cognitive Dysfunction 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Inflammation (Inflammations) 01/2018
1	Fatty Liver 07/2015
1	Wasting Syndrome (Wasting Disease) 07/2015
1	Liver Diseases (Liver Disease) 08/2013

Drug/Important Bio-Agent (IBA)

5	4-biphenylamineIBA 01/2020 - 06/2012
3	CarcinogensIBA 01/2019 - 06/2012
3	EnzymesIBA 01/2019 - 07/2003
3	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 05/2012
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020 - 12/2016
2	Pharmaceutical PreparationsIBA 01/2019 - 08/2013
2	DNA AdductsIBA 01/2019 - 04/2015
2	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 07/2015 - 06/2012
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 07/2015 - 04/2015
2	N-acetyltalosaminuronic acid (NAT)IBA 06/2012 - 05/2012
1	starlicideIBA 01/2022
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 12/2020
1	OsteocalcinIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020
1	EndostatinsIBA 01/2020
1	AminesIBA 01/2019
1	DystrophinIBA 01/2018
1	GlucocorticoidsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 12/2016
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	DioxinsIBA 07/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2015
1	Polychlorinated Dibenzodioxins (TCDD)IBA 07/2015
1	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 07/2015
1	AntioxidantsIBA 04/2015
1	A-Form DNA (A-DNA)IBA 06/2012
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 06/2012
1	AcetyltransferasesIBA 06/2012
1	Arylamine N-AcetyltransferaseIBA 05/2012

Therapy/Procedure

1	Glycemic Control 12/2020
1	Therapeutics 08/2013